Skip to main content
. 2019 Jun;8(3):736–751. doi: 10.21037/tcr.2019.04.10

Table 2. Gender distribution of gene-mutated patients.

Mutated genes Male Female
Cases Rate (%) Cases Rate (%)
EGFR 25 51.02 24 48.98
ALK 6 85.71 1 14.29
ROS1 2 50.00 2 50.00
MET 3 75.00 1 25.00
ERBB2 (Her2) 2 50.00 2 50.00
BRAF 0 0.00 2 100.00
KRAS 7 87.50 1 12.50